The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
An Algorithm for Subgraph Isomorphism
Ullmann, J. R. (1976) · Journal of the ACM · doi:10.1145/321921.321925 · Cited by 2,277
Wolber, G., & Langer, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049885e · Cited by 1,954
Monte Carlo-minimization approach to the multiple-minima problem in protein folding.
Li, Z., & Scheraga, H. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6611 · Cited by 1,468
Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9087-6 · Cited by 1,198
The computer program LUDI: A new method for the de novo design of enzyme inhibitors
B�hm, H.-J. (1992) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124387 · Cited by 835
Pharmacophore perception, development, and use in drug design
Güner, O. F. (2000) · Medical Entomology and Zoology · Cited by 689
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998) · Pure and Applied Chemistry · doi:10.1351/pac199870051129 · Cited by 529
Baroni, M., Cruciani, G., Sciabola, S., Perruccio, F., & Mason, J. S. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci600253e · Cited by 439
A genetic algorithm for flexible molecular overlay and pharmacophore elucidation
Jones, G., Willett, P., & Glen, R. C. (1995) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124324 · Cited by 390
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
A Review on Applications of Computational Methods in Drug Screening and Design
Lin, X., Li, X., & Lin, X. (2020) · Molecules · doi:10.3390/molecules25061375 · Cited by 718
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Computational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Pharmit: interactive exploration of chemical space
Sunseri, J., & Koes, D. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw287 · Cited by 420
Targeting protein–protein interactions as an anticancer strategy
Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401
“A pharmacophore model represents the chemical features of a set of compounds critical for efficient protein binding [49].”
BackgroundXu, Y., Wang, S., Hu, Q., Gao, S., Ma, X., Zhang, W., Shen, Y., Chen, F., Lai, L., & Pei, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky380 · Cited by 389
Drug Design by Pharmacophore and Virtual Screening Approach
Giordano, D., Biancaniello, C., Argenio, M. A., & Facchiano, A. (2022) · Pharmaceuticals · doi:10.3390/ph15050646 · Cited by 384
In silico methods for drug repurposing and pharmacology
Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P., & Dudley, J. T. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1337 · Cited by 326
Gentile, D., Patamia, V., Scala, A., Sciortino, M. T., Piperno, A., & Rescifina, A. (2020) · Marine Drugs · doi:10.3390/md18040225 · Cited by 319
Discovering Anti-Cancer Drugs via Computational Methods
Cui, W., Aouidate, A., Wang, S., Yu, Q., Li, Y., & Yuan, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00733 · Cited by 307
eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates
Pu, L., Naderi, M., Liu, T., Wu, H.-C., Mukhopadhyay, S., & Brylinski, M. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0282-6 · Cited by 212
“VS employing features provided by pharmacophore modeling [6] and quantitative structure-activity relationship (QSAR) analysis [7] can be performed in order to identify potentially active compounds.”
MethodUnleashing the power of generative AI in drug discovery
Gangwal, A., & Lavecchia, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103992 · Cited by 195
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18091271 · Cited by 61
“Pharmacophore modeling enabled researchers to define the essential features required for biological activity based on known active compounds, allowing for virtual screening without requiring detailed structural information about the target [41].”
Protein‐protein interactions as antibiotic targets: A medicinal chemistry perspective
Cossar, P. J., Lewis, P. J., & McCluskey, A. (2020) · Medicinal Research Reviews · doi:10.1002/med.21519 · Cited by 55
Verma, A. K., & Aggarwal, R. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13812 · Cited by 54
Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development
Ataeinia, B., & Heidari, P. (2021) · PET Clinics · doi:10.1016/j.cpet.2021.06.008 · Cited by 31
A Molecular Representation to Identify Isofunctional Molecules
Pinel, P., Guichaoua, G., Devaux, N., Gaston‐Mathé, Y., Hoffmann, B., & Stoven, V. (2025) · Molecular Informatics · doi:10.1002/minf.202400159 · Cited by 1
Metadata
- Authors
- Yang, S.-Y.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 15
- Issue
- 11-12
- Pages
- 444-450
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1992041755
- Cited by
- 901
- References
- 39
- FWCI
- 26.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.